Cencora Q1 2022 Earnings Report
Key Takeaways
AmerisourceBergen reported a strong first quarter with revenue increasing by 13.5% year-over-year to $59.6 billion. Adjusted diluted EPS increased by 18.3% to $2.58. The company has raised its adjusted diluted EPS guidance for fiscal year 2022 to a range of $10.60 to $10.90.
Revenue increased 13.5 percent year-over-year to $59.6 billion.
GAAP diluted EPS was $2.13 for the December quarter of fiscal 2022, compared to $1.81 in the prior year quarter.
Adjusted diluted EPS increased 18.3 percent to $2.58 in the fiscal first quarter.
Adjusted diluted EPS guidance has been raised from the previous range of $10.50 to $10.80 to a range of $10.60 to $10.90.
Cencora
Cencora
Forward Guidance
AmerisourceBergen is updating its fiscal year 2022 financial guidance to reflect the updated full year expectations from COVID therapy distribution and higher interest expense. Adjusted Diluted Earnings Per Share to be in the range of $10.60 to $10.90, raised from the previous range of $10.50 to $10.80.
Positive Outlook
- Adjusted operating income growth to be in the high-teens percent range, up from growth in the mid- to high-teens percent range
- U.S. Healthcare Solutions operating income to be in the range of $2.375 to $2.45 billion, representing growth of 5% to 9%, up from a range of $2.325 to $2.4 billion
Challenges Ahead
- Interest expense to be in the range of $210 to $215 million, up from growth in the mid-teens percent range.